Most Clicked StoriesMore >


Study examines bleeding risks of NSAIDS combined with anti-clotting drugs

AABB SmartBrief | Feb 25, 2015

Taking nonsteroidal anti-inflammatory drugs with antithrombotic drugs was associated with increased risk of major bleeding, a second heart attack and death for patients with a history of heart attacks, according to a study in the Journal of the American Medical Association. An analysis of the records of more than 60,000 heart attack survivors found bleeding events were about twice as likely for patients who had taken an NSAID along with clot-preventing drugs. Reuters (02/24)


Pathogen reduction technologies featured in February issue of AABB News

AABB SmartBrief | Feb 24, 2015

Dental stem cells converted into corneal stromal cells

AABB SmartBrief | Feb 24, 2015

Retinal tissue developed from stem cells, researchers report

AABB SmartBrief | Feb 23, 2015

Upcoming audioconference discusses clinical practice guidelines for platelet transfusions

AABB SmartBrief | Feb 27, 2015

Stem cell study examines prevalence of leukemia-related mutations by age

AABB SmartBrief | Feb 27, 2015

Drug shows efficacy in addressing infantile hemangioma

AABB SmartBrief | Feb 23, 2015

Clostridium difficile germinates in digestive tract within 24 hours

AABB SmartBrief | Feb 24, 2015

Portola's factor Xa inhibitor antidote receives FDA orphan designation

AABB SmartBrief | Feb 27, 2015

Reminder: PBM learning modules now available

AABB SmartBrief | Feb 26, 2015


Find AABB SmartBrief Issues by Date:



AABB News More >


Upcoming audioconference discusses clinical practice guidelines for platelet transfusions

AABB SmartBrief | Feb 27, 2015

Reminder: PBM learning modules now available

AABB SmartBrief | Feb 26, 2015

Reminder: Renew your AABB membership

AABB SmartBrief | Feb 25, 2015

Pathogen reduction technologies featured in February issue of AABB News

AABB SmartBrief | Feb 24, 2015

AABB CareerLink matches candidates with jobs in patient blood management, transfusion medicine and cellular therapies

AABB SmartBrief | Feb 23, 2015




Sign up for AABB SmartBrief



Designed specifically for the transfusion medicine and cellular therapy community, AABB SmartBrief is a FREE, daily e-mail newsletter. It provides a summary of the most important news in our field to members of AABB and beyond. To save time and stay smart, sign up today to receive AABB SmartBrief, free of charge. Learn more